Macloras Tablets 1 mg Tablet
PDF Leaflet Revision Date: 24 October 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of idiopathic Parkinson's disease.
Dosage (summary)
1 mg once daily, with or without levodopa.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
- Paediatric population
Pregnancy & Breastfeeding
Safety in pregnancy and breastfeeding not established.
Key Drug Interactions
- MAO inhibitors
- Pethidine
- Fluoxetine
- Fluvoxamine
- Dextromethorphan
- Sympathomimetics
Contraindications
- Hypersensitivity to rasagiline
- Moderate to severe hepatic impairment
Common side effects
- Headache
- Depression
- Dyskinesia
- Nausea
- Dry mouth
Counselling Points
- Avoid driving if drowsy
- Monitor for impulse control issues
- Report any new skin lesions
Serious warnings
- Risk of impulse control disorders
- Somnolence and sudden sleep onset
- Potential melanoma risk
Important Disclaimer
The Macloras Tablets 1 mg Tablet professional information leaflet below is the property of Macleods Pharmaceuticals Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
